Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

CLSN

Celsion Corp.

Celsion Corporation is a cutting-edge oncology drug development company that utilizes proprietary heat-activated liposomal technology to create targeted chemotherapeutic oncology drugs. The company...

Celsion Corp. Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

NYR (

Nyrada

Nyrada Inc is a new pharmaceutical company based in Australia, focused on drug discovery and development for cardiovascular and neurology conditions. The company is focused on tackling diseases and...

Nyrada Annual Report 2023

Healthcare Biotechnology ASX 1-10

PGEN

Precigen

Precigen, Inc., a leader in gene and cellular therapies, is revolutionizing the biopharmaceutical industry with their innovative technology. The company operates through two dynamic segments, Bioph...

Precigen Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

MTEM

Molecular Templates, Inc.

Austin-based Molecular Templates, Inc. is a clinical stage biopharmaceutical company with a mission to combat cancer and other serious diseases through the discovery and development of biologic the...

Molecular Templates, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

CBM

Cambrex Corporation

In an article for the Wall Street Journal, it was noted that Cambrex Corporation is a forward-thinking life sciences company that is focused on developing products, services, and technologies that ...

Cambrex Corporation Annual Report 2017

Healthcare Biotechnology NYSE 1001-5000

KRYS

Krystal Biotech, Inc.

Krystal Biotech, Inc., a burgeoning biotechnology firm committed to the development of genetic medicines for rare diseases, has announced the pursuit of innovative treatments for an array of severe...

Krystal Biotech, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

LGND

Ligand Pharmaceuticals

California-based Ligand Pharmaceuticals Incorporated is at the forefront of developing new technologies that help pharmaceutical companies discover and develop medicines globally. The biopharmaceut...

Ligand Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

BPTH

Bio-Path

Bio-Path Holdings, Inc. is making waves in the field of oncology-focused RNAi nano particle drug development in the United States. Utilizing groundbreaking technology, the company's products are ba...

Bio-Path Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

RCE

Recce Pharmaceuticals

Recce Pharmaceuticals Ltd is a cutting-edge biotech company that is leading the charge in developing and bringing to market a new class of synthetic antibiotics that are designed to combat the grow...

Recce Pharmaceuticals Annual Report 2023

Healthcare Biotechnology ASX 1-10

VNDA

Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a notable biopharmaceutical company, has devoted its resources and expertise to target the highly unmet medical needs of patients worldwide. The company's flagship produ...

Vanda Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

EBS

Emergent BioSolutions

Emergent BioSolutions Inc., a life sciences company based in Maryland, is dedicated to offering preparedness and response solutions geared towards accidental, deliberate, and naturally occurring pu...

Emergent BioSolutions Annual Report 2023

Healthcare Biotechnology NYSE 1001-5000

BLPH

Bellerophon Therapeutics

Bellerophon Therapeutics, a clinical-stage company focusing on cardiopulmonary disease treatments, is advancing its proprietary INOpulse platform for the treatment of pulmonary hypertension. Curren...

Bellerophon Therapeutics Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

HOTH

Hoth Therapeutics, Inc.

Hoth Therapeutics, a clinical-stage biopharmaceutical firm, is striving to meet pressing medical needs by developing innovative therapies. Among its promising treatments are HT-001, a topical solut...

Hoth Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

MIST

Milestone Pharmaceuticals Inc.

Montreal-based biopharmaceutical firm Milestone Pharmaceuticals Inc. has dedicated its efforts to the development and commercialization of cardiovascular medicines. The company's leading product ca...

Milestone Pharmaceuticals Inc. Annual Report 2023

Healthcare Biotechnology LSE 11-50

FENC

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc.: An Emerging Biopharmaceutical Company Providing Innovative Treatments Fennec Pharmaceuticals Inc., previously known as Adherex Technologies Inc., is a notable biopharm...

Fennec Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10